Roche has reported a net income of SFr6.6bn ($7.4bn) in H1 2024, a 4% decline co...
Mankind Pharma has announced a definitive agreement for the acquisition of Bhara...
AbbVie has reported a 32.1% decrease in net earnings attributable to the company...
The European Commission has awarded conditional marketing authorisation for Pfiz...
The ODAC highlighted that perioperative trials should separately evaluate the ef...
The EMA recommended a label update that allows the drug to be used to reduce car...
The FDA approval is based on data gathered from two Phase III studies where over...
The current approval, which is based on data from non-human primates and healthy...
The UK MHRA has authorised Pfizer-BioNTech’s adapted Comirnaty vaccine against t...
The Phase II antibody drug conjugate received FDA fast track designation against...
3D printing is replacing traditional prototype development approaches across var...
JNJ-2056 is being investigated in the Phase IIb ReTain study which enrols partic...
Ipsen will pay $111m in cash and equity upfront to gain the global rights, exclu...
Sandoz launched the biosimilar of J&J’s Stelara in Europe in partnership with Sa...
A Phase II study for ConSynance’s triple monoamine reuptake inhibitor CSTI-500 i...
The US FDA has expanded approval to BioMarin Pharmaceutical's BRINEURA to includ...
